IRIS
GRASSO, Silvana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.060
EU - Europa 5.771
AS - Asia 4.937
SA - Sud America 1.997
AF - Africa 154
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 6
AN - Antartide 1
Totale 29.938
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.929
SG - Singapore 1.906
BR - Brasile 1.782
IE - Irlanda 1.460
SE - Svezia 1.240
CN - Cina 1.194
VN - Vietnam 854
UA - Ucraina 728
IT - Italia 603
DE - Germania 568
HK - Hong Kong 522
FI - Finlandia 303
RU - Federazione Russa 263
GB - Regno Unito 242
IN - India 108
FR - Francia 75
AR - Argentina 72
CA - Canada 60
TR - Turchia 54
AT - Austria 49
BD - Bangladesh 49
CZ - Repubblica Ceca 41
ZA - Sudafrica 40
BE - Belgio 39
MX - Messico 37
EC - Ecuador 36
NL - Olanda 34
MA - Marocco 33
UZ - Uzbekistan 33
IQ - Iraq 32
CO - Colombia 26
IR - Iran 25
VE - Venezuela 24
PL - Polonia 22
ID - Indonesia 20
ES - Italia 19
PK - Pakistan 19
CL - Cile 17
TN - Tunisia 17
DZ - Algeria 15
CI - Costa d'Avorio 14
PY - Paraguay 13
AE - Emirati Arabi Uniti 12
JP - Giappone 12
PE - Perù 12
UY - Uruguay 12
LV - Lettonia 11
NP - Nepal 11
RO - Romania 11
CH - Svizzera 10
IL - Israele 10
JM - Giamaica 10
AZ - Azerbaigian 9
EG - Egitto 9
EU - Europa 8
GE - Georgia 8
SN - Senegal 8
KG - Kirghizistan 7
LT - Lituania 7
SA - Arabia Saudita 7
BY - Bielorussia 6
JO - Giordania 6
KZ - Kazakistan 6
AL - Albania 5
AM - Armenia 5
KE - Kenya 5
KR - Corea 5
PA - Panama 5
TT - Trinidad e Tobago 5
AU - Australia 4
BA - Bosnia-Erzegovina 4
DO - Repubblica Dominicana 4
HN - Honduras 4
KW - Kuwait 4
LB - Libano 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
CR - Costa Rica 3
DK - Danimarca 3
EE - Estonia 3
GR - Grecia 3
LU - Lussemburgo 3
OM - Oman 3
RS - Serbia 3
BG - Bulgaria 2
BO - Bolivia 2
HU - Ungheria 2
MD - Moldavia 2
ML - Mali 2
MY - Malesia 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
AD - Andorra 1
AQ - Antartide 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
CG - Congo 1
DM - Dominica 1
GA - Gabon 1
Totale 29.914
Salva come PNG Salva come JPEG
Città #
Dallas 9.876
Dublin 1.458
Jacksonville 1.377
Chandler 949
Singapore 863
Nyköping 812
Ashburn 629
Dong Ket 629
Beijing 532
Hong Kong 520
Princeton 265
Cambridge 254
Medford 232
Dearborn 216
Des Moines 188
Los Angeles 179
Boardman 152
The Dalles 150
Ann Arbor 143
Messina 140
São Paulo 117
Buffalo 113
Milan 95
Munich 89
Ho Chi Minh City 88
San Mateo 75
Lancaster 69
Jinan 68
Tianjin 62
New York 58
Wilmington 58
Redondo Beach 57
Rio de Janeiro 54
Woodbridge 54
Belo Horizonte 49
Hanoi 47
Vienna 46
Shenyang 45
Moscow 43
Brussels 36
Nanjing 36
Brno 35
Brooklyn 35
Houston 34
Porto Alegre 31
Tashkent 31
Augusta 30
Haikou 27
Pune 26
Zhengzhou 25
Helsinki 24
Hyderabad 24
Johannesburg 24
Brasília 23
Seattle 23
Amsterdam 22
Campinas 22
Chicago 22
Curitiba 21
Fuzhou 21
Santa Clara 21
Taizhou 21
Turku 21
Stockholm 20
Hebei 19
Ningbo 19
Salvador 19
St Petersburg 19
Warsaw 19
Ardabil 18
Montreal 18
Changsha 17
London 17
Nanchang 15
Norwalk 15
Quito 15
Abidjan 14
Boston 14
Da Nang 14
Dhaka 14
Guangzhou 14
Guarulhos 14
Istanbul 14
Manaus 14
Goiânia 13
Mumbai 13
Nova Iguaçu 13
Poplar 13
Rome 13
Hangzhou 12
Jiaxing 12
Montevideo 12
San Francisco 12
Shenzhen 12
Toronto 12
Washington 12
Atlanta 11
Campo Grande 11
Denver 11
Haiphong 11
Totale 22.021
Salva come PNG Salva come JPEG
Nome #
[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines: synthesis and stereochemistry 4.671
[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines: stereochemistry and anticonvulsant activity 4.644
1-aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: Novel AMPA receptor antagonists 231
1-Halophenyl-N-N'-di-(2-heteroaryl)-methylenediamine and 1-halophenyl-3-(2-heteroaryl)-thiazolidin-4-ones as potential hypotensive agents. 227
1-Phenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 223
1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: non-competitive AMPA receptors antagonists 214
1-(2-Fluorophenyl)- and 1-(3-fluorophenyl)-1H,3H-thiazolo[3,4- a]benzimidazole 210
1-Adamantanamine derivatives as potential anti-HIV agents 201
1-Aryl-6,7-methylenedioxy-3H-quinazolin-4-ones as anticonvulsant agents 199
1-Halophenyl-N-N'-di-(2-heteroaryl)-methylenediamine and 1-halophenyl-3-(2-heteroaryl)-thiazolidin-4-ones as potential hypotensive agents. 199
1H,3H-Thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 164
2,3,3a,4-Tetraidro-1H-pirrolo[1,2-a]benzimidazol-1-oni 3a-sostituiti 152
5H-[1,2,4]OXADIAZOLO[5,4-D][1,5]BENZOTHIAZEPINES - SYNTHESIS AND STEREOCHEMISTRY 141
2,3,3a,4-Tetraidro-1H-pirrolo[1,2-a]benzimidazol-1-oni isomeri ottenuti da 4-cloro-1,2-fenilendiamina ed acidi 3-acilpropionici 140
7,8-methylenedioxy-4H-2,3-benzodiazepin-4-ones as novel AMPA receptor antagonists 140
3H-Azirino[1,2-d][1,4]benzodiazepin-4(5H)-ones: synthesis and stereochemistry 138
Derivati adamantanici a potenziale attività antivirale. 137
3H-AZIRINO[1,2-D][1,4]BENZODIAZEPIN-4 (5H)-ONES - SYNTHESIS AND STEREOCHEMISTRY 136
5H-[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines as anticonvulsant agents in DBA/2 mice. 136
Cap. 21 - Antitrombotici 135
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 129
3,5-Dihydro-5-methyl-7,8-methylenedioxy-4H-2,3-benzodiazepin-4-ones as novel noncompetitive AMPA receptor antagonists 124
Synthesis and biological evaluation of novel peptidomimetics as rhodesain inhibitors 123
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli-sostituiti 121
Cross-Metathesis Reactions in the Synthesis of Constrained Dipeptide Mimics as Potent Falcipain-2 Inhibitors. 119
Constrained peptidomimetics as antiplasmodial falcipain-2 inhibitors 119
2,3-Benzodiazepines as potential AMPA receptors antagonists 118
Design, synthesis and molecular modeling studies on peptidomimetic vinyl esters as falcipan-2 inhibitors 116
Design, synthesis and biological evaluation of novel dipeptide-like rhodesain inhibitors containing a conformationally constrained 3-bromoisoxazoline warhead 115
DEVELOPMENT OF NOVEL PEPTIDOMIMETIC ANALOGUES OF A HIGHLY POTENT AND SELECTIVE FALCIPAIN-2 INHIBITOR CONTANING A VINYL ESTER MOIETY 114
Ciclofunzionalizzazione di 1,4- e 1,5-benzodiazepine: sintesi e stereochimica di nuovi sistemi eteropoliciclici ottenuti per reazione con acidi mercaptoacetici 113
7,9-Dihydro-1,3-dioxolo[4,5-h][2,3]benzodiazepin-8(7H)-ones as anticonvulsant agents 113
Identification of noncovalent proteasome inhibitors with high selectivity for chymotrypsin-like activity by a multistep structure-based virtual screening 113
4,4-Methylenedioxybenzene derivatives: synthesis and investigation of the mechanism of their anticonvulsant activity. 112
G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitors: Current Trends and Future Perspectives 111
A simple and efficient synthesis of GYKI 52466 and GYKI 52895 109
Cross-Metathesis Reactions in the Synthesis of Constrained Dipeptide Mimics as Potent Falcipain-2 Inhibitors 109
13C NMR study of tetrahydrothiazolo[3,2-d][1,4]benzodiazepin-3(2H)-ones. 107
6,7-Methylenedioxyphtalazin-1(2H)-ones as novel and potent anticonvulsant agents 107
Vincamina: sintesi e caratteristiche spettroscopiche 106
Development of novel 1,4-benzodiazepine-based Michael acceptors as antitrypanosomal agents 106
Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma. 106
Annelated 1,5-benzothiazepines 106
Peptidomimetics containing a vinyl ketone warhead as falcipain-2 inhibitors 102
Evaluation of curcumin irreversibility 102
Immunoproteasome-selective inhibitors: a promising strategy to treat hematologic malignancies, autoimmune and inflammatory diseases 101
Novel peptidomimetics containing different α,β-unsaturated electrophilic functions, as falcipain-2 inhibitors 100
AMINOPYRAZINYL DERIVATIVES - SYNTHESIS AND EVALUATION OF ANTIINFLAMMATORY AND RELATED ACTIVITIES 99
Development of Novel Peptidomimetics Containing a VinylSulfone Moiety as Proteasome Inhibitors 99
4,5-Methylenedioxybenzene derivatives: synthesis and investigation of the mechanism of their anticonvulsant activity. 98
6,7-Methylenedioxyquinazolin-4-ones as Anticonvulsant Agents 98
Development of Novel Peptide-based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs) 98
Compounds with potential anti-tumor activity VII. Synthesis and anti-tumor activity of 1-aryl-N,N'-di(1,3,4-thiadiazol-2-yl)methylenediamines 97
ANNELATED 1,5-BENZODIAZEPINES .1. 3-MEMBERED, 4-MEMBERED, AND 5-MEMBERED RINGS. 97
ANTICONVULSANT ACTIVITY OF PYRROLO[1',2'-1,2]IMIDAZO[4,5- B]PYRIDINES, PYRROLO[2',1'-2,3]IMIDAZO[4,5-C] PYRIDINES AND PYRROLO[2,1-F]PURINES IN DBA/2 MICE 96
Novel potent AMPA/kainate receptor antagonists: Synthesis and anticonvulsant activity of a series of 2-[(4- alkylsemicarbazono)-(4-aminophenyl)methyl]-4,5- methylenedioxyphenylacetic acid alkyl esters 95
Falcipain-2 inhibitors 95
An unexpected reaction between 2,3-dihydro-2,2,4-trimethyl-1H-1,5-benzodiazepine and mercaptoacetic acid 95
Drug combination studies of curcumin and genistein against rhodesain of Trypanosoma brucei rhodesiense 95
ANNELATED 1,5-BENZODIAZEPINES .2. 6 MEMBERED RINGS 92
6,7-Metilendiossiftalazin-1(2H)-oni: una nuova classe di potenti agenti anticonvulsivanti. 92
Design, synthesis and biological evaluation of peptidomimetics boronic acids targeting 20S proteasome 91
Development of novel amides as non covalent inhibitors of immunoproteasome 91
The Inhibition of Cysteine Proteases Rhodesain and TbCatB: A Valuable Approach to Treat Human African Trypanosomiasis 91
Development of novel dipeptide-like rhodesain inhibitors containing the 3-bromoisoxazoline warhead in a constrained conformation 91
Synthesis, Chiral Resolution and Pharmacological Evaluation of a 2,3-Benzodiazepine-Derived Noncompetitive AMPA Receptor Antagonist 90
Synthesis and anticonvulsant activity of novel and potent 1- aryl-7,8-methylenedioxy-1,2,3,5-tetrahydro-4H-2,3- benzodiazepin-4-ones 89
STRATEGIES FOR SYNTHESIS OF CONFORMATIONALLY CONSTRAINED GLUTAMATE ANALOGUES 89
Identification of novel 5 arylidene-3-phenyl-2 thioxoimidazolidin-4-ones as inhibitors of the chymotrypsin-like activities of the constitutive and immuno-proteasomes 89
Composti a presumibile attività antitumorale. IV - Sintesi ed attività antileucemica di N,N'-di-[2-(1,3,4-tiadiazolil)]metilendiamine 1-sostituite 88
Synthesis and anticonvulsant activity of novel and potent 6,7- methylenedioxyphthalazin-1(2H)-ones 88
Reazioni di cross metathesis: applicazione alla sintesi di peptidomimetici potenziali inibitori di falcipaina-2 88
Sintesi ed attività di nuovi agenti antiipertensivi. 88
Structure-activity study of 2,3-benzodiazepin-4-ones noncompetitive AMPAR antagonists: identification of the 1-(4-amino,3-methylphenyl)-3,5-dihydro-7,8-ethylenedioxy-4H-2,3-benzodiazepin-4-one as neuroprotective agent 88
Development of novel N-3-bromoisoxazolin-5-yl substituted 2,3-benzodiazepines as noncompetitive AMPAR antagonists 88
Development of novel peptide-based Michael acceptors targeting rhodesain and falcipain-2 for the treatment of neglected tropical diseases (NTDs) 88
Synthesis of 2-semicarbazonomethyl-4,5-methylenedioxyphenylacetic acids as anticonvulsant agents 87
7-Chloro-1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4- a]benzimidazole and 1-(2,6-difluorophenyl)-6-methyl-1H,3H- thiazolo[3,4-a]benzimidazole 87
6,7-Methylenedioxyphthalazin-1(2H)-ones as novel and potent anticonvulsant agents 87
Development of peptidomimetic boronates as proteasome inhibitors 86
Development of novel 1,4-benzodiazepines as antitrypanosomal agents 86
Characterization of the binding site in a series of AMPA receptor antagonists. 85
Pyrrolo[1',2':1,2]imidazo[4,5-b]pyridines, pyrrolo[2',1':2,3]imidazo[4,5-c]pyridines and pyrrolo[2,1-f]purines as potential benzodiazepine receptor ligands. 85
Synthesis and structure-activity relationship of 2,3-benzodiazepines AMPA receptor antagonists 85
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli 1-sostituiti 84
Anti-HIV agents II. Synthesis and in vitro anti-HIV activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles. 84
DEVELOPMENT OF NOVEL PEPTIDOMIMETICS CONTAINIG A VINYL SULFONE MOIETY AS PROTEASOME INHIBITORS 84
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF PEPTIDOMIMETIC FALCIPAIN-2 INHIBITORS AS ANTIMALARIAL AGENTS 84
The reaction between 3-acylpropionic acids and the o-phenylenediamine: n.m.r and X-ray analysis of 3a-phenyl-2,3,3a,4-tetrahydropyrrolo[1,2-a]benzimidazol-1-one. 83
Compounds with potential antitumor activity. Note VIII 1-Alkyl-N,N'-di(1,3,4-thiadiazol-2-yl)methylenediamines. 83
ANTI-HIV AGENTS .3. SYNTHESIS AND IN-VITRO ANTI-HIV ACTIVITY OF NOVEL 1H,3H-THIAZOLO[3,4-A]IMIDAZO[4,5-B]PYRIDINES 83
HIV-1 RT inhibitors containing a cyclofunctionalized benzimidazole system 82
Synthesis and anticonvulsant activity of novel and potent 2,3- benzodiazepine AMPA/kainate receptor antagonists 82
Sintesi e proprietà anticonvulsivanti di 3-(1,3,4-tiadiazol-2-il)tiazolidin-4-oni. 82
Anti-HIV agents .4. Synthesis and in vitro anti-HIV activity of novel 1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4- a]benzimidazoles 82
Synthesis of novel peptidomimetics as inhibitors of protozoan cysteine proteases falcipain-2 and rhodesain 82
2,3-Benzodiazepine-based noncompetitive AMPAR antagonists: design, synthesis, binding affinity and mechanism of inhibition of the GluR2Qflip homomeric receptor channel 82
NOVEL PYRROLO- AND THIAZOLO-IMIDAZOLES 81
Structure-activity relationships of 2,3-benzodiazepines as AMPA/KA receptor antagonists 80
Synthesis, chiral resolution and enantiopharmacology of a potent 2,3-benzodiazepine as noncompetitive AMPA receptor antagonist 80
Totale 20.148
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.815
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.815
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.567 0 0 0 0 0 211 10 215 70 213 164 684
2021/20221.643 10 350 30 70 86 2 103 61 36 61 295 539
2022/20234.222 367 326 182 300 328 467 84 224 1.779 16 98 51
2023/2024847 91 127 69 198 93 92 16 31 4 46 14 66
2024/20254.394 95 44 105 361 205 48 18 1.059 1.223 200 317 719
2025/202613.065 419 3.321 7.312 1.057 853 103 0 0 0 0 0 0
Totale 30.290